BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27744392)

  • 1. Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.
    Trombetta AC; Pizzorni C; Ruaro B; Paolino S; Sulli A; Smith V; Cutolo M
    J Rheumatol; 2016 Nov; 43(11):2033-2041. PubMed ID: 27744392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.
    Cutolo M; Ruaro B; Pizzorni C; Ravera F; Smith V; Zampogna G; Paolino S; Seriolo B; Cimmino M; Sulli A
    J Rheumatol; 2014 May; 41(5):881-6. PubMed ID: 24692525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis.
    Cutolo M; Zampogna G; Vremis L; Smith V; Pizzorni C; Sulli A
    J Rheumatol; 2013 Jan; 40(1):40-5. PubMed ID: 23118114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.
    Cestelli V; Manfredi A; Sebastiani M; Praino E; Cannarile F; Giuggioli D; Ferri C
    Mod Rheumatol; 2017 Jan; 27(1):110-114. PubMed ID: 27310203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study.
    Cutolo M; Ferrone C; Pizzorni C; Soldano S; Seriolo B; Sulli A
    J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study.
    Rotondo C; Nivuori M; Chialà A; Praino E; Matucci Cerinic M; Cutolo M; Lapadula G; Iannone F
    Scand J Rheumatol; 2018 Jul; 47(4):311-318. PubMed ID: 29409385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan fosters microvascular de-remodelling in systemic sclerosis.
    Guiducci S; Bellando Randone S; Bruni C; Carnesecchi G; Maresta A; Iannone F; Lapadula G; Matucci Cerinic M
    Clin Rheumatol; 2012 Dec; 31(12):1723-5. PubMed ID: 23053682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trial.
    Schioppo T; Orenti A; Boracchi P; De Lucia O; Murgo A; Ingegnoli F
    Rheumatology (Oxford); 2018 Aug; 57(8):1408-1416. PubMed ID: 29733400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study.
    Shah P; Murray AK; Moore TL; Herrick AL
    J Rheumatol; 2011 Sep; 38(9):2079-80. PubMed ID: 21885525
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nailfold capillaroscopy and blood flow laser-doppler analysis of the microvascular damage in systemic sclerosis: preliminary results].
    Secchi ME; Sulli A; Pizzorni C; Cutolo M
    Reumatismo; 2009; 61(1):34-40. PubMed ID: 19370186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.
    Hettema ME; Zhang D; Stienstra Y; Smit AJ; Bootsma H; Kallenberg CG
    Clin Rheumatol; 2009 Jul; 28(7):825-33. PubMed ID: 19350343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients.
    Sulli A; Ruaro B; Alessandri E; Pizzorni C; Cimmino MA; Zampogna G; Gallo M; Cutolo M
    Ann Rheum Dis; 2014 Jan; 73(1):247-51. PubMed ID: 23644551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.
    Bellando-Randone S; Lepri G; Bruni C; Blagojevic J; Radicati A; Cometi L; De Paulis A; Matucci-Cerinic M; Guiducci S
    Clin Rheumatol; 2016 Jan; 35(1):127-32. PubMed ID: 26631100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis.
    Di Battista M; Da Rio M; Logiacco A; Barsotti S; Della Rossa A; Mosca M
    Scand J Rheumatol; 2023 May; 52(3):302-305. PubMed ID: 35880719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.
    Blagojevic J; Abignano G; Avouac J; Cometi L; Frerix M; Bellando-Randone S; Guiducci S; Bruni C; Huscher D; Jaeger VK; Lóránd V; Maurer B; Nihtyanova S; Riemekasten G; Siegert E; Tarner IH; Vettori S; Walker UA; Czirják L; Denton CP; Distler O; Allanore Y; Müller-Ladner U; Moggi-Pignone A; Matucci-Cerinic M; Del Galdo F;
    Clin Rheumatol; 2020 Jan; 39(1):27-36. PubMed ID: 31111363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital ulcers in scleroderma patients: A retrospective observational study.
    De Cata A; Inglese M; Molinaro F; De Cosmo S; Rubino R; Bernal M; Mazzoccoli G
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):180-7. PubMed ID: 26684622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers.
    Lüders S; Friedrich S; Ohrndorf S; Glimm AM; Burmester GR; Riemekasten G; Backhaus M
    Rheumatology (Oxford); 2017 Nov; 56(11):1865-1873. PubMed ID: 28340234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.